Thanks for posts. Both make sense, but the naked short selling makes the most sense. This implicates the usual NASDAQ players, and the brokerages supporting market makers. While Williams may be using these market makers given the enormous slice of shares he owns, I find it hard to believe his leadership team would be willing to tolerate and even participate in NSS, as this could create red flags for FDA.
It takes a lot of guts for many of you to stay committed to a stock in this position. Cheers to you. Be safe.
News 
Market Data 
Discover 
AI
